Staking Our Claim

About

↓

Reaching New Destinations

Pliant Therapeutics is a clinical-stage biopharmaceutical company leading the way in developing new treatments for fibrotic diseases. As fibrosis is a complex disease, few available treatments for fibrosis exist today. We are committed to advancing novel treatments and prepared to change the fibrosis treatment landscape.

Pliant is diving deep to understand the molecular drivers of fibrotic diseases to unlock potentially safer, and more effective therapies for patients.


Life Science Leader

Read our CEO’s feature
in Life Science Leader



→


Mission, Vision, and
Core Values

Mission

Build the leading fibrosis company by combining world class expertise in fibrosis-biology, chemistry and technology to develop best-in-class, tissue-specific, inhibitors of fibrotic diseases.

Vision

Transform the lives of patients who suffer from debilitating and deadly fibrotic diseases.

Core Values

Our journey to change outcomes for patients with fibrotic diseases is guided by the following principles.

For Our Patients
We listen and learn from you. We embrace the challenge of curing fibrotic diseases. We foster innovation and science. We are true to the data and act with integrity.

For Our Team
We treat each other with respect. We are responsible for our actions. We communicate transparently and honestly. We build and cultivate a collaborative spirit.

Our Company Commitment

Core Values

On our journey to change outcomes for patients with fibrotic diseases, we are guided by the following principles.

For Our Patients

 

We listen and learn from you. We embrace the challenge of curing fibrotic diseases. We foster innovation and science. We are true to the data and act with integrity.

For Our Team

 

We treat each other with respect. We are responsible for our actions. We communicate transparently and honestly. We build and cultivate a collaborative spirit.

Our Responsibility
While patients are at the center of our corporate responsibility efforts, we recognize that operating in a sustainable manner benefits all of our stakeholders, including employees, investors, environment, communities, and the patients we seek to serve. In that regard, we have undertaken various environmental, social and governance (“ESG”) initiatives, including in the areas of: environmental sustainability; access to our investigational therapies; continuing education and support; inclusion, diversity and development of our team; charitable contributions; and commitment to compliance and ethical business conduct.